GlucoCEST MRI in Oncology

NACompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

January 6, 2017

Primary Completion Date

September 1, 2019

Study Completion Date

October 8, 2019

Conditions
Head and Neck Squamous Cell CarcinomaLymphomaGlioma
Interventions
OTHER

Glucose infusion

Infusion of 20% dextrose (drug) and using this as an imaging tracer in detecting and staging tumours.

DIAGNOSTIC_TEST

Magnetic Resonance Imaging (MRI)

MRI scanners (device) use strong magnetic fields, radio waves, and field gradients to generate images of the organs in the body. Specifically using the MRI scanner with the infusion of dextrose in detecting and staging tumours.

DIAGNOSTIC_TEST

FDG PET

FDG is a sugar (glucose) labelled with a small amount of radioactivity which goes to parts of the body that use glucose for energy. PET/CT images are acquired on a single scanner. An FDG PET scan can be used to assess the presence, location and severity of cancers.

Trial Locations (1)

NW1 2PG

University College London Hospital, London

Sponsors

Collaborators (1)

All Listed Sponsors
lead

University College, London

OTHER

collaborator

Cancer Research UK

OTHER